In Central and South America, snakebite envenomation is primarily caused by Bothrops spp. snakes, whose venom contains harmful serine proteases that current antivenoms don't fully neutralize.
Researchers designed 6-mer peptides specifically to inhibit these venom serine proteases, aiming to enhance the effectiveness of antivenoms.
They identified two promising inhibitor peptides, one of which showed potential in selectively inhibiting the venom's serine proteases without affecting human proteases, suggesting a new avenue for improving treatment for snakebites.